-52%

est. 2Y upside i

Climate TechSeries A

Stage: early. Country: England

Rank

#655

Sector

Biomaterials, Advanced Materials, Sustainable Textiles

Est. Liquidity

~4Y

Data Quality

Data: Medium

PACT presents a strong upside opportunity for a job seeker, driven by its innovative, patented biomaterial technology and significant market tailwinds from sustainability demands.

Last updated: March 10, 2026

Bull (35%)+300%

PACT's patented Oval biomaterial achieves rapid market penetration, securing major partnerships with luxury brands and expanding successfully into automotive and interiors. Driven by strong regulatory tailwinds and superior product performance, revenue scales to over $100M ARR within two years, justifying a premium valuation of $720M+.

Base (40%)+50%

PACT continues to gain traction with early adopters, demonstrating commercial viability and securing a moderate number of new contracts. Production scales steadily, and the company raises a Series B round at a healthy step-up, reaching $30-40M ARR and a valuation of $270M in two years.

Bear (25%)-80%

PACT faces significant challenges in achieving cost parity at scale or struggles with production bottlenecks. Well-funded competitors or incumbent material manufacturers introduce effective alternatives, eroding PACT's market share. This leads to slower growth, a flat or down round, and a valuation of $36M, significantly impacting common stock value due to liquidation preferences.

Est. time to liquidity~4.0 years

Preference Stack Risk

high

Investors hold $47M in liquidation preferences ahead of common stock, representing 26.1% of the estimated current valuation of $180M.

Dilution Risk

high

As a Series A company, PACT will likely require multiple additional funding rounds (Series B, C, etc.) before a liquidity event, leading to significant future dilution for common shareholders.

Secondary Liquidity

none

Given PACT's early stage (Series A), there is currently no active secondary market or tender offers for employee equity.

View all 3 open roles at PACT →

Last updated: February 22, 2026

Questions to Ask at the Interview

Strategic questions based on PACT's data — designed to show you've done your homework.

  • 1

    “Given the high capital intensity of biomaterials manufacturing, how is PACT planning to manage its cash burn and secure future funding rounds efficiently to avoid excessive dilution?”

  • 2

    “PACT has a strong competitive moat with Oval. How does the company plan to maintain this advantage against well-funded competitors like MycoWorks and Natural Fiber Welding, especially as they also scale their offerings?”

  • 3

    “With the recent Series A funding, what are the key milestones PACT aims to achieve in the next 18-24 months regarding commercialization, production scale-up, and market penetration, particularly in new sectors like automotive?”

Community

Valuation Sentiment

Our model estimates -52% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.